{"id":413,"date":"2023-11-08T16:30:01","date_gmt":"2023-11-08T20:30:01","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/?p=413"},"modified":"2023-11-08T16:30:01","modified_gmt":"2023-11-08T20:30:01","slug":"fda-pushes-back-enforcement-deadline-for-mocra-facility-registration-and-product-listing-requirements","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2023\/11\/08\/fda-pushes-back-enforcement-deadline-for-mocra-facility-registration-and-product-listing-requirements\/","title":{"rendered":"FDA Pushes Back Enforcement Deadline for MoCRA Facility Registration and Product Listing Requirements"},"content":{"rendered":"<p>Today, FDA\u00a0<a href=\"https:\/\/www.fda.gov\/cosmetics\/cosmetics-news-events\/fda-issues-compliance-policy-cosmetic-product-facility-registration-and-cosmetic-product-listing\">announced<\/a>\u00a0updated\u00a0<a href=\"https:\/\/www.fda.gov\/media\/173606\/download\">guidance<\/a>\u00a0regarding its MoCRA rollout.<\/p>\n<p>FDA\u00a0 does not intend to enforce the requirements related to cosmetic product facility registration and cosmetic product listing for an additional six months after the December 29, 2023, statutory deadline, or until\u00a0<strong>July 1, 2024<\/strong>, to provide regulated industry additional time to comply with these requirements.<\/p>\n<p>To read the full text of this post by <a href=\"https:\/\/www.duanemorris.com\/attorneys\/kellyabonner.html\" target=\"_blank\" rel=\"noopener\">Kelly Bonner,<\/a>\u00a0 please <a href=\"https:\/\/blogs.duanemorris.com\/fashionretailbrandedconsumergoods\/2023\/11\/08\/breaking-news-fda-pushes-back-enforcement-deadline-for-mocra-facility-registration-and-product-listing-requirements-to-july-1-2024\/\" target=\"_blank\" rel=\"noopener\">visit the <em>Duane Morris Fashion, Retail and Consumer Branded Products Blog<\/em><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Today, FDA\u00a0announced\u00a0updated\u00a0guidance\u00a0regarding its MoCRA rollout. FDA\u00a0 does not intend to enforce the requirements related to cosmetic product facility registration and cosmetic product listing for an additional six months after the December 29, 2023, statutory deadline, or until\u00a0July 1, 2024, to provide regulated industry additional time to comply with these requirements. To read the full text &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2023\/11\/08\/fda-pushes-back-enforcement-deadline-for-mocra-facility-registration-and-product-listing-requirements\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FDA Pushes Back Enforcement Deadline for MoCRA Facility Registration and Product Listing Requirements&#8221;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[29,639,641,630],"ppma_author":[521],"class_list":["post-413","post","type-post","status-publish","format-standard","hentry","category-general","tag-fda","tag-kelly-bonner","tag-mocra","tag-regulatory"],"authors":[{"term_id":521,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","author_category":"1","last_name":"Sullivan","first_name":"Margaret","job_title":"","user_url":"http:\/\/www.duanemorris.com","description":"<a href=\"http:\/\/www.duanemorris.com\">Visit the Duane Morris website.<\/a>"}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/comments?post=413"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/413\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/media?parent=413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/categories?post=413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/tags?post=413"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/ppma_author?post=413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}